Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil effectively controls blood pressure in severe cases, but may cause fluid retention and edema.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Some psychiatric medications can cause reversible hair loss.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Minoxidil lowers blood pressure more effectively but has more side effects, so try hydralazine first.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Hodgkin's lymphoma can show up as hair loss.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Taking Propecia might lead to the development of cataracts.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Ruxolitinib treatment may cause eyelash growth.